======= WSB1 ======= == Gene Information == * **Official Symbol**: WSB1 * **Official Name**: WD repeat and SOCS box containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26118|26118]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6I7|Q9Y6I7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WSB1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WSB1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610091|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes type II iodothyronine deiodinase/DIO2. Confers constitutive instability to HIPK2 through proteasomal degradation. {ECO:0000269|PubMed:15601820, ECO:0000269|PubMed:15965468, ECO:0000269|PubMed:18093972}. |SOCS box| |WD40| |intracellular| |protein polyubiquitination| |post-translational protein modification| |protein ubiquitination| |protein modification by small protein conjugation| |protein modification by small protein conjugation or removal| |intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp224|CB-839 10μM R05 exp224]]|-4.01| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-2.94| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-2.83| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-2.65| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-2.57| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-2.54| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.27| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-2.18| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-2.11| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.97| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.94| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.93| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.89| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.88| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.88| |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|-1.8| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.79| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-1.79| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|-1.79| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.75| |[[:results:exp453|B02 10μM R08 exp453]]|-1.74| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.72| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.72| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.74| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.74| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.78| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|2.19| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.49| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.59| ^Gene^Correlation^ |[[:human genes:r:rps6kb1|RPS6KB1]]|0.432| |[[:human genes:p:pmm2|PMM2]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3518 * **Expression level (log2 read counts)**: 7.18 {{:chemogenomics:nalm6 dist.png?nolink |}}